Skip to content

Clinical trials

Phase 1/2 Breast Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Country / region: Russia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20171
20182
20202
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Pfizer2
Eisai Limited1
Eli Lilly and Company1
Kidney Cancer Research Bureau1
Puma Biotechnology, Inc.1
Zeno Alpha Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms9
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Ovarian Epithelial2
Neoplasm Metastasis2
Ovarian Neoplasms2
Prostatic Neoplasms2
Acrocephalosyndactylia1
Biliary Tract Neoplasms1
Brain Neoplasms1
Breast Neoplasms, Male1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.